IMU 1.96% 5.2¢ imugene limited

Why IMU is a multi multi bagger, page-12797

  1. 218 Posts.
    lightbulb Created with Sketch. 396
    This puts Genentec as owner of tecentric(Atezolizumab) in competition with Merck for IMU in a trial sense.
    Merck being involved in keytruda combo trial.
    Two HUGE Pharmas heavily invested in reviewing our IMU drugs.
    I know we are all waiting but this is great news for cancer sufferers and means all majors are interested in what LC and team have put together.
    I am a believer so I think its just amazing that a small company in essentially 6 years (since first trial of Hervaxx) has created so much value.
    I dont think they have wasted a dollar of shareholders funds.

    Lets hope the share price reflects this value I perceive soon.

    GLTA shareholder
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.2¢
Change
0.001(1.96%)
Mkt cap ! $373.3M
Open High Low Value Volume
5.1¢ 5.2¢ 5.1¢ $81.52K 1.598M

Buyers (Bids)

No. Vol. Price($)
4 35642 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
5.2¢ 820074 6
View Market Depth
Last trade - 10.04am 04/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.